Literature DB >> 23220033

Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction.

Soraya Scuderi1, Agata Grazia D'Amico, Alessandro Castorina, Rosa Imbesi, Maria Luisa Carnazza, Velia D'Agata.   

Abstract

Breakdown of outer blood retinal barrier (BRB) due to the disruption of tight junctions (TJs) is one of the main factors accounting for diabetic macular edema (DME), a major complication of diabetic retinopathy. Previously it has been shown that PACAP and VIP are protective against several types of retinal injuries. However, their involvement in the maintenance of outer BRB function during DME remains uncovered. Here, using an in vitro model of DME, we explored the effects of both PACAP and VIP. Human retinal pigment epithelial cells (ARPE19) were cultured for 26 days either in normal glucose (5.5 mM, NG) or in high glucose (25 mM, HG). In addition, to mimic the inflammatory aspect of the diabetic milieu, cells were also treated with IL-1β (NG+IL-1β and HG+IL-1β). Effects of PACAP or VIP on cells permeability were evaluated by measuring both apical-to-basolateral movements of fluorescein isothyocyanate (FITC) dextran and transepithelial electrical resistance (TEER). Expression of TJ-related proteins was evaluated by immunoblot. Results demonstrated that NG+IL-1β and, to a greater extent, HG+IL-1β significantly increased FITC-dextran diffusion, paralleled by decreased TEER. PACAP or VIP reversed both of these effects. Furthermore, HG+IL-1β-induced reduction of claudin-1 and ZO-1 expression was reversed by PACAP and VIP. Occludin expression was not affected in any of the conditions tested. Altogether, these finding show that both peptides counteract HG+IL-1β-induced damage in ARPE19 cells, suggesting that they might be relevant to the maintenance of outer BRB function in DME.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220033     DOI: 10.1016/j.peptides.2012.11.015

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  23 in total

1.  Nap Interferes with Hypoxia-Inducible Factors and VEGF Expression in Retina of Diabetic Rats.

Authors:  Agata Grazia D'Amico; Grazia Maugeri; Claudio Bucolo; Salvatore Saccone; Concetta Federico; Sebastiano Cavallaro; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2016-12-01       Impact factor: 3.444

2.  Davunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic death.

Authors:  Soraya Scuderi; Agata Grazia D'Amico; Alessandro Castorina; Concetta Federico; Giuseppina Marrazzo; Filippo Drago; Claudio Bucolo; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2014-02-02       Impact factor: 3.444

3.  Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced Diabetes.

Authors:  Soraya Scuderi; Agata Grazia D'amico; Concetta Federico; Salvatore Saccone; Gaetano Magro; Claudio Bucolo; Filippo Drago; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2015-02-13       Impact factor: 3.444

4.  PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina.

Authors:  Agata Grazia D'Amico; Grazia Maugeri; Rita Reitano; Claudio Bucolo; Salvatore Saccone; Filippo Drago; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2015-07-23       Impact factor: 3.444

5.  The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.

Authors:  A Vaczy; D Reglodi; T Somoskeoy; K Kovacs; E Lokos; E Szabo; A Tamas; T Atlasz
Journal:  J Mol Neurosci       Date:  2016-08-26       Impact factor: 3.444

6.  Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.

Authors:  K Szabadfi; D Reglodi; A Szabo; B Szalontai; A Valasek; Gy Setalo; P Kiss; A Tamas; M Wilhelm; R Gabriel
Journal:  Neurotox Res       Date:  2016-01-06       Impact factor: 3.911

7.  Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood-Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats.

Authors:  Yuanjian Fang; Hui Shi; Reng Ren; Lei Huang; Takeshi Okada; Cameron Lenahan; Marcin Gamdzyk; Zachary D Travis; Qin Lu; Lihui Tang; Yi Huang; Keren Zhou; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Neurotherapeutics       Date:  2020-09-11       Impact factor: 7.620

8.  Increased hippocampal CREB phosphorylation in dopamine D3 receptor knockout mice following passive avoidance conditioning.

Authors:  Agata Grazia D'Amico; Soraya Scuderi; Gian Marco Leggio; Alessandro Castorina; Filippo Drago; Velia D'Agata
Journal:  Neurochem Res       Date:  2013-10-08       Impact factor: 3.996

9.  NAP reduces murine microvascular endothelial cells proliferation induced by hyperglycemia.

Authors:  Agata Grazia D'Amico; Soraya Scuderi; Grazia Maugeri; Sebastiano Cavallaro; Filippo Drago; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2014-05-30       Impact factor: 3.444

10.  VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1.

Authors:  Haoshen Shi; Thomas W Carion; Youde Jiang; Jena J Steinle; Elizabeth A Berger
Journal:  Prostaglandins Other Lipid Mediat       Date:  2016-03-26       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.